ERCC1 and osteoporosis: This study demonstrated that the combination of dasatinib and quercetin effectively eliminated senescent mouse embryonic fibroblasts, and that periodic drug administration extended healthspan in Ercc1 knock-out mice, thereby delaying age-related symptoms and pathologies, including osteoporosis (41).